Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure
- 1 April 1997
- journal article
- Published by Elsevier in Kidney International
- Vol. 51 (4), 1170-1181
- https://doi.org/10.1038/ki.1997.160
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Advanced oxidation protein products as a novel marker of oxidative stress in uremiaKidney International, 1996
- Monocyte/macrophage response to β2-microglobulin modified with advanced glycation end productsKidney International, 1996
- N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue ProteinsBiochemistry, 1995
- Glycation of Human .beta.2-Microglobulin in Patients with Hemodialysis-Associated Amyloidosis: Identification of the Glycated SitesBiochemistry, 1994
- β2-Microglobulin Modified with Advanced Glycation End Products Induces Interleukin-6 from Human Macrophages: Role in the Pathogenesis of Hemodialysis-Associated AmyloidosisBiochemical and Biophysical Research Communications, 1994
- Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: Vitamins A, E, and iron statusFree Radical Biology & Medicine, 1994
- Erythrocyte Redox State in Uremic Anemia: Effects of Hemodialysis and Relevance of Glutathione MetabolismActa Haematologica, 1994
- Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.The Journal of Experimental Medicine, 1991
- Role of Oxidative Stress in Development of Complications in DiabetesDiabetes, 1991
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988